MedImmune 551-1088 (#468)
Laufzeit: 01.01.2015 - 31.12.2015
imported
Kurzfassung
A phase II randomized open-label study of MEDI-551 in adults
with relapsed or refractory DLBCL
Laufzeit: 01.01.2015 - 31.12.2015
A phase II randomized open-label study of MEDI-551 in adults
with relapsed or refractory DLBCL